Allegion (NYSE:ALLE) Price Target Raised to $137.00

Allegion (NYSE:ALLE - Get Free Report) had its price objective upped by analysts at Barclays from $135.00 to $137.00 in a report issued on Monday, Benzinga reports. The firm currently has an "underweight" rating on the scientific and technical instruments company's stock. Barclays's price objective suggests a potential downside of 3.74% from the company's previous close.

Other analysts have also issued reports about the stock. Mizuho upped their price target on shares of Allegion from $135.00 to $150.00 and gave the stock a "neutral" rating in a research report on Thursday, October 17th. Wells Fargo & Company upped their target price on shares of Allegion from $137.00 to $152.00 and gave the company an "equal weight" rating in a report on Monday, October 7th. Robert W. Baird lifted their price target on Allegion from $145.00 to $152.00 and gave the stock a "neutral" rating in a report on Friday. Finally, StockNews.com raised Allegion from a "hold" rating to a "buy" rating in a research report on Saturday, July 27th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $144.60.

Allegion Trading Down 0.2 %

Shares of Allegion stock traded down $0.27 on Monday, hitting $142.33. 1,335,185 shares of the company's stock traded hands, compared to its average volume of 713,293. Allegion has a one year low of $95.97 and a one year high of $156.10. The company has a debt-to-equity ratio of 1.40, a current ratio of 1.66 and a quick ratio of 1.23. The stock has a market capitalization of $12.45 billion, a PE ratio of 23.43, a price-to-earnings-growth ratio of 4.50 and a beta of 1.12. The firm's 50-day moving average price is $142.34 and its two-hundred day moving average price is $130.16.

Allegion (NYSE:ALLE - Get Free Report) last announced its quarterly earnings results on Thursday, October 24th. The scientific and technical instruments company reported $2.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.98 by $0.18. The company had revenue of $967.10 million during the quarter, compared to the consensus estimate of $970.70 million. Allegion had a return on equity of 47.21% and a net margin of 15.08%. The company's revenue for the quarter was up 5.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.94 earnings per share. On average, research analysts expect that Allegion will post 7.26 EPS for the current fiscal year.

Hedge Funds Weigh In On Allegion

Large investors have recently made changes to their positions in the company. Stephens Inc. AR acquired a new position in Allegion in the 3rd quarter valued at $225,000. AustralianSuper Pty Ltd acquired a new position in shares of Allegion in the third quarter valued at about $494,000. abrdn plc increased its position in Allegion by 2.7% during the third quarter. abrdn plc now owns 197,817 shares of the scientific and technical instruments company's stock worth $28,855,000 after acquiring an additional 5,287 shares during the period. Pallas Capital Advisors LLC acquired a new stake in Allegion in the 3rd quarter worth about $620,000. Finally, Concord Wealth Partners bought a new stake in Allegion in the 3rd quarter valued at about $29,000. Institutional investors own 92.21% of the company's stock.

About Allegion

Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door controls and systems and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors, accessories, and other.